Table 2. Final chosen LBL epitopes from HTLV-1 antigenic proteins employed to develop the MEBV construct.

Sr. No	LBL Epitopes	Protein	Position	Antigenicity	Immunogenicity
1	PCLLLFLPFQILSG	AP	38	0.6293	0.0873
2	TNYTCIVCIDRASL	GP	221	1.0062	0.23894
3	LTLPFNWTHCFDPQ	GP	267	1.2029	0.44788
4	RRGLDLLFWEQGGL	GP	379	0.9600	0.3664
5	HQITWDPIDGRVIG	PT	52	0.8070	0.65428